Treatment withdrawal · children and adolescents with anxiety disorders
It is very uncertain whether DCS and cognitive and behavioural therapies changes treatment acceptability: withdrawals from treatment compared with placebo and cognitive and behavioural therapies (very low certainty).
1 finding from 1 review
Acceptability · people with social phobia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: acceptability of treatment · patients with anxiety disorders
It is very uncertain whether morita therapy plus pharmacological therapy changes acceptability drop‐outs for any reason compared with pharmacological therapy alone (very low certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · participants with panic disorder
It is very uncertain whether rTMS + pharmacotherapy changes acceptability: dropouts for any reason number of dropouts compared with sham rTMS + pharmacotherapy (very low certainty).
1 finding from 1 review
Acceptability ‐ dropouts due to adverse effects · participants with panic disorder
It is very uncertain whether rTMS + pharmacotherapy changes acceptability: dropouts for adverse effects number of dropouts compared with sham rTMS + pharmacotherapy (very low certainty).
1 finding from 1 review
Improvment of social function: Self‐reported social adaptation scale (SASS) (low=poor), acute effect SASS. Scale from: 0 to 60. · participants with panic disorder
1 finding from 1 review
Acceptability · somatoform disorders in adults
Natural products showed no clear difference in acceptability (all‐cause drop‐outs4) compared with placebo (low certainty).
1 finding from 1 review
Acceptability · somatoform disorders in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability · somatoform disorders in adults
Tricyclic antidepressants showed no clear difference in acceptability (all‐cause drop‐outs4) compared with another medication (low certainty).
1 finding from 1 review
Acceptability · somatoform disorders in adults
Antidepressants showed no clear difference in acceptability (all‐cause drop‐outs4) compared with a combination of medications (low certainty).
1 finding from 1 review
Acceptability · somatoform disorders in adults
New‐generation antidepressants showed no clear difference in acceptability (all‐cause drop‐outs) compared with placebo (low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · people with somatoform disorders and medically unexplained physical symptoms
Psychological therapy probably leads to lower acceptability 1 ‐ proportion of participants withdrawing during… compared with usual care or waiting list (moderate certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · people with somatoform disorders and medically unexplained physical symptoms
Psychological therapy showed no clear difference in acceptability 1 ‐ proportion of participants withdrawing during… compared with enhanced or structured care (moderate certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
1 finding from 1 review
Acceptability (number of participants lost to post‐treatment assessment) · patients with depression
It is very uncertain whether mindfulness‐based 'third wave' cognitive and behavioural therapies changes treatment acceptability at post‐treatment Dropout rates compared with other psychological therapies (very low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · patients with depression
It is very uncertain whether mindfulness‐based 'third wave' cognitive and behavioural therapies changes treatment acceptability at compared with other psychological therapies (very low certainty).
1 finding from 1 review
Acceptability (number of participants lost to post‐treatment assessment) · depression
It is very uncertain whether third wave CBT changes treatment acceptability (dropout) at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Acceptability of treatment Drop‐out for any reason · adults with Major Depressive Disorder
It is very uncertain whether amitriptyline changes acceptability of treatment Drop‐out for any reason compared with placebo (very low certainty).
1 finding from 1 review